Itraconazole is manufactured by several pharmaceutical companies. Some of the key manufacturers include Mylan Pharmaceuticals, Teva Pharmaceuticals, and other generic drug producers.
Who holds the patents for itraconazole?
Patents related to itraconazole, including those for its synthesis and formulations, have been held by various entities over time. For example, Janssen Pharmaceutica, a Johnson & Johnson company, was an originator of itraconazole and held early patents. As patents expire, other companies can develop and market generic versions. Information on specific patent expirations and challenges can be found through resources like DrugPatentWatch.com [1].
When does itraconazole's patent exclusivity expire?
The patent exclusivity for itraconazole has largely expired for many of its original formulations. This has paved the way for generic competition. Specific patent expiry dates can vary depending on the patent and the country.
What are the different forms of itraconazole available?
Itraconazole is available in several pharmaceutical forms, including oral capsules and an oral solution. These formulations are used to treat a variety of fungal infections.
How does itraconazole work to treat fungal infections?
Itraconazole belongs to a class of antifungal medications called triazoles. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. By disrupting ergosterol production, itraconazole weakens the fungal cell membrane, leading to cell death or inhibiting its growth [2].
What are the main uses of itraconazole?
Itraconazole is prescribed to treat a range of fungal infections, including aspergillosis, blastomycosis, histoplasmosis, and onychomycosis (fungal nail infections). It is also used for candidiasis in certain situations [2].
What are the common side effects associated with itraconazole?
Common side effects of itraconazole can include nausea, vomiting, diarrhea, abdominal pain, headache, and dizziness. Less common but more serious side effects can occur, and patients should consult with their healthcare provider regarding any concerns [2].
Are there alternatives to itraconazole for fungal infections?
Yes, there are alternative antifungal medications available, depending on the specific type and severity of the fungal infection. These may include other azoles like fluconazole or voriconazole, as well as other classes of antifungals such as echinocandins or amphotericin B [2].
How does itraconazole compare to other azole antifungals?
Itraconazole has a broad spectrum of activity against many fungi. Compared to other azoles like fluconazole, itraconazole may be more effective against certain molds and dimorphic fungi. However, drug interactions and potential for liver toxicity are considerations for all azole antifungals [2].
What is the pricing of itraconazole?
The price of itraconazole can vary significantly based on the manufacturer, dosage form, quantity, and pharmacy. Generic itraconazole is generally more affordable than brand-name versions, which are less common due to patent expirations.
What are the regulatory approvals for itraconazole?
Itraconazole is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for the treatment of specific fungal infections. Manufacturers must adhere to strict manufacturing standards and undergo regulatory review for approval.
Where can I find more information on itraconazole patents and manufacturing?
Detailed information on itraconazole patents, including their status and expiration dates, as well as a broader landscape of pharmaceutical patents, can be accessed through specialized databases such as DrugPatentWatch.com [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.ncbi.nlm.nih.gov/books/NBK538772/